Murine ascitic fluids contain varying amounts of an inhibitor that interferes with complement-mediated effector functions of monoclonal antibodies.
The ability of murine monoclonal antibodies (mAbs), directed to the inner core of Gram-negative bacterial lipopolysaccharide (LPS, endotoxin), to enhance complement-mediated killing of bacteria, was investigated. The mAbs were tested as present in ascitic fluid. It was found that ascites contains an factor that inhibited the activity of complement. This effect was evident in assays for complement-mediated lysis of antibody-coated Gram-negative bacteria (bacterial killing) or of opsonised red blood cells. Moreover, the amount of inhibitor was found to vary from one ascites to another and spanned a 60-fold range. Thus, in vitro or in vivo experiments where complement is known to play a determining role may yield incorrect results when ascites is used as a source of antibody; the use of ascites prepared from irrelevant antibody as a negative control does not eliminate this problem.
D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology*; D001201:Ascites / Q000276:immunology*; D015169:Colony Count, Microbial; D003168:Complement Fixation Tests; D015941:Complement Hemolytic Activity Assay; D003169:Complement Inactivator Proteins / Q000276:immunology*; D003602:Cytotoxicity, Immunologic; D000939:Epitopes / Q000276:immunology; D004912:Erythrocytes / Q000276:immunology; D008070:Lipopolysaccharides / Q000276:immunology*; D051379:Mice; D012475:Salmonella / Q000276:immunology*
D000911:Antibodies, Monoclonal; D003169:Complement Inactivator Proteins; D000939:Epitopes; D008070:Lipopolysaccharides